Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Levin, E. G., Lustig, Y., Cohen, C., Fluss, R., Indenbaum, V., Amit, S., Doolman, R., Asraf, K., Mendelson, E., Ziv, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114583 · Cited by 1,703 · see citing works

Evolution of antibody immunity to SARS-CoV-2

Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674 · see citing works

A guide to vaccinology: from basic principles to new developments

Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593 · see citing works

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Bergwerk, M., Gonen, T., Lustig, Y., Amit, S., Lipsitch, M., Cohen, C., Mandelboim, M., Levin, E. G., Rubin, C., Indenbaum, V., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2109072 · Cited by 1,345 · see citing works

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03324-6 · Cited by 1,343 · see citing works

Humoral Immunity Due to Long-Lived Plasma Cells

Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249 · see citing works

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Kalkstein, N., Mizrahi, B., Alroy-Preis, S., Ash, N., Milo, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114255 · Cited by 1,169 · see citing works

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claër, L., Quentric, P., Fadlallah, J., Devilliers, H., Ghillani, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd2223 · Cited by 1,037 · see citing works

Waning Immunity after the BNT162b2 Vaccine in Israel

Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Haas, E. J., Milo, R., Alroy-Preis, S., Ash, N., & Huppert, A. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114228 · Cited by 1,034 · see citing works

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · Science · doi:10.1126/science.abm0829 · Cited by 873 · see citing works

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Barda, N., Dagan, N., Cohen, C., Hernán, M. A., Lipsitch, M., Kohane, I. S., Reis, B. Y., & Balicer, R. D. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02249-2 · Cited by 860 · see citing works

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

Turner, J. S., O’Halloran, J. A., Kalaidina, E., Kim, W., Schmitz, A. J., Zhou, J. Q., Lei, T., Thapa, M., Chen, R. E., Case, J. B., et al. (2021) · Nature · doi:10.1038/s41586-021-03738-2 · Cited by 831 · see citing works

Recent progress in mucosal vaccine development: potential and limitations

Lycke, N. Y. (2012) · Nature reviews. Immunology · doi:10.1038/nri3251 · Cited by 815 · see citing works

Mucosal vaccines — fortifying the frontiers

Lavelle, E. C., & Ward, R. W. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00583-2 · Cited by 763 · see citing works

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Wang, Z., Muecksch, F., Schaefer-Babajew, D., Finkin, S., Viant, C., Gaebler, C., Hoffmann, H. H., Barnes, C. O., Cipolla, M., Ramos, V., et al. (2021) · Nature · doi:10.1038/s41586-021-03696-9 · Cited by 721 · see citing works

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination

Goel, R. R., Apostolidis, S. A., Painter, M. M., Mathew, D., Pattekar, A., Kuthuru, O., Gouma, S., Hicks, P., Meng, W., Rosenfeld, A. M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi6950 · Cited by 655 · see citing works

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J. M., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00675-9 · Cited by 638 · see citing works

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

Turner, J. S., Kim, W., Kalaidina, E., Goss, C. W., Rauseo, A. M., Schmitz, A. J., Hansen, L., Haile, A., Klebert, M. K., Pusic, I., et al. (2021) · Nature · doi:10.1038/s41586-021-03647-4 · Cited by 515 · see citing works

The establishment of resident memory B cells in the lung requires local antigen encounter

Allie, S. R., Bradley, J., Mudunuru, U., Schultz, M. D., Graf, B. A., Lund, F. E., & Randall, T. D. (2018) · Nature Immunology · doi:10.1038/s41590-018-0260-6 · Cited by 398 · see citing works

The phenotype and fate of the antibody‐forming cells of the splenic foci

Smith, K. G. C., Hewitson, T. D., Nossal, G. J. V., & Tarlinton, D. M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260226 · Cited by 344 · see citing works

Secretory immunity with special reference to the oral cavity

Brandtzæg, P. (2013) · Journal of Oral Microbiology · doi:10.3402/jom.v5i0.20401 · Cited by 319 · see citing works

Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination

Palm, A.-K. E., & Henry, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01787 · Cited by 281 · see citing works

COVID-19 dynamics after a national immunization program in Israel

Rossman, H., Shilo, S., Meir, T., Gorfine, M., Shalit, U., & Segal, E. (2021) · Nature Medicine · doi:10.1038/s41591-021-01337-2 · Cited by 232 · see citing works

The germinal center reaction

Gatto, D., & Brink, R. A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.007 · Cited by 218 · see citing works

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases

Carsetti, R., Zaffina, S., Mortari, E. P., Terreri, S., Corrente, F., Capponi, C., Palomba, P., Mirabella, M., Cascioli, S., Palange, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610300 · Cited by 195 · see citing works

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals

(2022) · doi:10.1016/j.cell.2022.01.027 · Cited by 179 · see citing works

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals

Lederer, K., Parvathaneni, K., Painter, M. M., Bettini, E., Agarwal, D., Lundgreen, K. A., Weirick, M., Goel, R. R., Xu, X., Drapeau, E. M., et al. (2021) · doi:10.1101/2021.09.16.21263686 · Cited by 179 · cited 2× · see citing works

Stromal niches, plasma cell differentiation and survival

Moser, K., Tokoyoda, K., Radbruch, A., MacLennan, I. C. M., & Manz, R. A. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.004 · Cited by 152 · see citing works

Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients

Ko, J., Joo, E., Park, S., Baek, J. Y., Kim, W. D., Jee, J., Kim, C., Jeong, C., Kim, Y.-J., Shon, H. J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072268 · Cited by 120 · see citing works

Long-Lived Plasma Cells in Mice and Men

Brynjolfsson, S. F., Berg, L. P., Ekerhult, T. O., Rimkutė, I., Wick, M. J., Mårtensson, I., & Grimsholm, O. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02673 · Cited by 118 · see citing works

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2

Mudgal, R. K., Nehul, S., & Tomar, S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1805992 · Cited by 103 · see citing works

High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines

Pape, K. A., Dileepan, T., Kabage, A. J., Kozysa, D., Batres, R., Evert, C., Matson, M., Lopez, S., Krueger, P. D., Graiziger, C. T., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109823 · Cited by 101 · see citing works

The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory

Grimsholm, O., Mortari, E. P., Davydov, A. N., Shugay, M., Obraztsova, A., Bocci, C., Marasco, E., Marcellini, V., Aranburu, A., Farroni, C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.022 · Cited by 94 · see citing works

SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best

Salinas, A. F., Mortari, E. P., Terreri, S., Quintarelli, C., Pulvirenti, F., Cecca, S. D., Guercio, M., Milito, C., Bonanni, L., Auria, S., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01133-0 · Cited by 83 · see citing works

Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA

Mortari, E. P., Russo, C., Vinci, M. R., Terreri, S., Salinas, A. F., Piccioni, L., Alteri, C., Colagrossi, L., Coltella, L., Ranno, S., et al. (2021) · Cells · doi:10.3390/cells10102541 · Cited by 70 · see citing works

SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers

Rovida, F., Cassaniti, I., Paolucci, S., Percivalle, E., Sarasini, A., Piralla, A., Giardina, F., Sammartino, J. C., Ferrari, A., Bergami, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26154-6 · Cited by 61 · see citing works

The life span of short-lived plasma cells is partly determined by a block on activation of apoptotic caspases acting in combination with endoplasmic reticulum stress

Auner, H. W., Beham‐Schmid, C., Dillon, N., & Sabbattini, P. M. R. (2010) · Blood · doi:10.1182/blood-2009-10-250423 · Cited by 57 · see citing works

The Future of SARS-CoV-2 Vaccination — Lessons from Influenza

Monto, A. S. (2021) · New England Journal of Medicine · doi:10.1056/nejmp2113403 · Cited by 51 · see citing works

Covid-19 vaccination: evidence of waning immunity is overstated

Scott, J. A., Richterman, A. G., & Çevik, M. (2021) · BMJ · doi:10.1136/bmj.n2320 · Cited by 35 · see citing works

Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency

Salinas, A. F., Mortari, E. P., Terreri, S., Milito, C., Zaffina, S., Perno, C. F., Locatelli, F., Quinti, I., & Carsetti, R. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.08.031 · Cited by 21 · see citing works

The Dynamic Change of Antibody Index Against COVID-19 Is a Powerful Diagnostic Tool for the Early Phase of the Infection and Salvage PCR Assay Errors

Omata, M., Hirotsu, Y., Sugiura, H., Maejima, M., Nagakubo, Y., Amemiya, K., Hayakawa, M., Tsutsui, T., Kakizaki, Y., Mochizuki, H., et al. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.12.009 · Cited by 12 · see citing works

Adaptive Immune Responses and Immunity to SARS-CoV-2

Primorac, D., Vrdoljak, K., Brlek, P., Pavelić, E., Molnar, V., Matišić, V., Ivkošić, I. E., & Parčina, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848582 · Cited by 151 · see citing works

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic

Bertoletti, A., Bert, N. L., & Tan, A. T. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.008 · Cited by 115 · see citing works

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity

Lim, J. M. E., Tan, A. T., Bert, N. L., Hang, S. K., Low, J. G. H., & Bertoletti, A. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220780 · Cited by 114 · see citing works

Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study

Gazit, S., Saciuk, Y., Perez, G., Peretz, A., Pitzer, V. E., & Patalon, T. (2022) · BMJ · doi:10.1136/bmj-2022-071113 · Cited by 87 · see citing works

Mucosal plasma cells are required to protect the upper airway and brain from infection

Wellford, S. A., Moseman, A. P., Dao, K., Wright, K., Chen, A. P., Plevin, J. E., Liao, T.-C., Mehta, N. U., & Moseman, E. A. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.017 · Cited by 73 · see citing works

Defending against SARS-CoV-2: The T cell perspective

Almendro-Vázquez, P., Laguna‐Goya, R., & Paz‐Artal, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107803 · Cited by 64 · see citing works

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

Wagner, A., Garner‐Spitzer, E., Schötta, A., Orola, M. J., Wessely, A., Zwazl, I., Ohradanova‐Repic, A., Weseslindtner, L., Tajti, G., Gebetsberger, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889138 · Cited by 58 · see citing works

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose

Rénia, L., Goh, Y. S., Rouers, A., Bert, N. L., Chia, W. N., Chavatte, J., Fong, S., Chang, Z. W., Zhuo, N. Z., Tay, M. Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32312-1 · Cited by 58 · see citing works

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection

Pušnik, J., Monzon‐Posadas, W. O., Zorn, J., Peters, K., Baum, M., Proksch, H., Schlüter, C. B., Alter, G., Menting, T., & Streeck, H. (2023) · Nature Communications · doi:10.1038/s41467-023-36250-4 · Cited by 53 · see citing works

Olfactory immunology: the missing piece in airway and CNS defence

Wellford, S. A., & Moseman, E. A. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00972-9 · Cited by 49 · see citing works

Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics

Newby, M., Fogarty, C., Allen, J., Butler, J., Fadda, E., & Crispin, M. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167928 · Cited by 44 · see citing works

Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70

Brook, B., Duval, V., Barman, S., Speciner, L., Sweitzer, C., Khanmohammed, A., Menon, M., Foster, K., Ghosh, P., Abedi, K., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adm8451 · Cited by 44 · see citing works

AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans

Grigoryan, L., Feng, Y., Bellusci, L., Lai, L., Wali, B., Ellis, M. L., Yuan, M., Arunachalam, P. S., Hu, M., Kowli, S., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adi8039 · Cited by 43 · see citing works

Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study

Fedele, G., Trentini, F., Schiavoni, I., Abrignani, S., Antonelli, G., Baldo, V., Baldovin, T., Bandera, A., Bonura, F., Clerici, P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1021396 · Cited by 38 · see citing works

The past, current and future epidemiological dynamic of SARS-CoV-2

Balloux, F., Tan, C. C. S., Swadling, L., Richard, D., Jenner, C., Maini, M. K., & van Dorp, L. (2022) · Oxford Open Immunology · doi:10.1093/oxfimm/iqac003 · Cited by 37 · see citing works

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine

Azzi, L., Gasperina, D. D., Veronesi, G., Shallak, M., Maurino, V., Baj, A., Gianfagna, F., Cavallo, P., Dentali, F., Tettamanti, L., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2022.104435 · Cited by 37 · see citing works

Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues

Davis‐Porada, J., George, A. B., Lam, N., Caron, D. P., Gray, J. I., Huang, J., Hwu, J., Wells, S. B., Matsumoto, R., Kubota, M., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.10.003 · Cited by 36 · see citing works

Olfactory immune response to SARS-CoV-2

Wellford, S. A., & Moseman, E. A. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01119-5 · Cited by 35 · see citing works

Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components

Busà, R., Sorrentino, M. C., Russelli, G., Amico, G., Miceli, V., Miele, M., Bella, M. D., Timoneri, F., Gallo, A., Zito, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856657 · Cited by 34 · see citing works

Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination

Barateau, V., Peyrot, L., Saade, C., Pozzetto, B., Brengel‐Pesce, K., Elsensohn, M., Allatif, O., Guibert, N., Compagnon, C., Mariano, N., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade0550 · Cited by 31 · see citing works

SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers

Porru, S., Monaco, M. G. L., Spiteri, G., Carta, A., Pezzani, M. D., Lippi, G., Gibellini, D., Tacconelli, E., Vecchia, I. D., Sala, E., et al. (2022) · Vaccines · doi:10.3390/vaccines10081193 · Cited by 30 · see citing works

Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa

Declercq, J., Gerlo, S., Nevel, S. V., Ruyck, N. D., Holtappels, G., Delesie, L. M., Tobback, E., Lammens, I., Gerebtsov, N., Sedeyn, K., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn2364 · Cited by 27 · see citing works

Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles

Touizer, E., Alrubayyi, A., Ford, R., Hussain, N., Gerber, P., Shum, H.-L., Rees-Spear, C., Muir, L., Gea-Mallorquí, E., Kopycinski, J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105862 · Cited by 21 · see citing works

Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2

Lenart, K., Cerveira, R. A., Hellgren, F., Ols, S., Sheward, D. J., Kim, C., Cagigi, A., Gagné, M., Davis, B. J., Germosen, D., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00806-2 · Cited by 26 · see citing works

A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike

Zhang, Y., Lu, M., Mahesh, K. C., Kim, E., Shamseldin, M. M., Ye, C., Dravid, P., Chamblee, M., Park, J., Hall, J. M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201616119 · Cited by 26 · see citing works

Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine

de Assis, F. L., Hoehn, K. B., Zhang, X., Kardava, L., Smith, C. D., Merhebi, O. E., Buckner, C. M., Trihemasava, K., Wang, W., Seamon, C. A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112780 · Cited by 26 · see citing works

Immunogenicity of SARS-CoV-2 vaccines in patients with cancer

Kakkassery, H., Carpenter, E., Patten, P., & Irshad, S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.07.006 · Cited by 23 · see citing works

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV

Polvere, J., Fabbiani, M., Pastore, G., Rancan, I., Rossetti, B., Durante, M., Zirpoli, S., Morelli, E., Pettini, E., Lucchesi, S., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00245-5 · Cited by 23 · see citing works

Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding

Hartley, G. E., Fryer, H. A., Gill, P. A., Boo, I., Bornheimer, S. J., Hogarth, P. M., Drummer, H. E., O’Hehir, R. E., Edwards, E. S. J., & van Zelm, M. C. (2024) · npj Vaccines · doi:10.1038/s41541-024-00919-8 · Cited by 23 · see citing works

Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms

Pineda-Peña, A.-C., Hasegawa, K., Pavot, V., Berry, C., Combadière, B., Cortés-Garcia, G., McDermott, A. B., & Sridhar, S. (2025) · npj Vaccines · doi:10.1038/s41541-025-01302-x · Cited by 22 · see citing works

The immune response as a double‐edged sword: The lesson learnt during the COVID ‐19 pandemic

Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., & Capobianchi, M. R. (2022) · Immunology · doi:10.1111/imm.13564 · Cited by 22 · see citing works

Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines

Matsumura, T., Takano, T., & Takahashi, Y. (2022) · International Immunology · doi:10.1093/intimm/dxac064 · Cited by 22 · see citing works

AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

Aksyuk, A. A., Bansal, H., Wilkins, D. E., Stanley, A. M., Sproule, S., Maaske, J., Sanikommui, S., Hartman, W. R., Sobieszczyk, M. E., Falsey, A. R., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100882 · Cited by 21 · see citing works

Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant

Mise‐Omata, S., Ikeda, M., Takeshita, M., Uwamino, Y., Wakui, M., Arai, T., Yoshifuji, A., Murano, K., Siomi, H., Nakagawara, K., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200525 · Cited by 19 · see citing works

The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age

Cinicola, B. L., Mortari, E. P., Zicari, A. M., Agrati, C., Bordoni, V., Albano, C., Fedele, G., Schiavoni, I., Leone, P., Fiore, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1094727 · Cited by 19 · see citing works

Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic review

Guerra, E. N. S., de Castro, V. T., dos Santos, J. A., Acevedo, A. C., & Chardin, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006040 · Cited by 18 · see citing works

Viral infection and antiviral immunity in the oral cavity

Hickman, H. D., & Moutsopoulos, N. M. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01100-x · Cited by 17 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity

Conti, M. G., Terreri, S., Terrin, G., Natale, F., Pietrasanta, C., Salvatori, G., Brunelli, R., Midulla, F., Papaevangelou, V., Carsetti, R., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac359 · Cited by 17 · see citing works

Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination

Qi, F., Cao, Y., Zhang, S., & Zhang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.964976 · Cited by 16 · see citing works

Waning immunity and the future of booster vaccination strategies in global vaccine programs post COVID-19

Biswas, R., Roy, A., Kayal, T., Basu, S., Ghosh, S., Ramaiah, S., & Anbarasu, A. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2626088 · Cited by 15 · see citing works

CD62L expression marks a functionally distinct subset of memory B cells

Hanson, C. H., Henry, B., Andhare, P., Lin, F. J., Pak, H., Turner, J. S., Adams, L. J., Liu, T., Fremont, D. H., Ellebedy, A. H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113542 · Cited by 15 · see citing works

Association between sex hormones and anti-S/RBD antibody responses to COVID-19 vaccines in healthcare workers

Anticoli, S., Dorrucci, M., Iessi, E., Chiarotti, F., Prinzio, R. R. D., Vinci, M. R., Zaffina, S., Puro, V., Colavita, F., Mizzoni, K., et al. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2273697 · Cited by 15 · see citing works

Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models

Warang, P., Singh, G., Moshir, M., Binazon, O., Laghlali, G., Chang, L. A., Wouters, H., Vanhoenacker, P., Notebaert, M., Elhemdaoui, N., et al. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2470542 · Cited by 14 · see citing works

T and B cell responses in different immunization scenarios for COVID-19: a narrative review

Mortari, E. P., Ferrucci, F., Zografaki, I., Carsetti, R., & Pacelli, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535014 · Cited by 13 · see citing works

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2

Monzon‐Posadas, W. O., Zorn, J., Peters, K., Baum, M., Proksch, H., Schlüter, C. B., Menting, T., Pušnik, J., & Streeck, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1066123 · Cited by 13 · see citing works

Durable immune responses after BNT162b2 vaccination in home-dwelling old adults

Hansen, L., Brokstad, K. A., Bansal, A., Zhou, F., Bredholt, G., Onyango, T. B., Sandnes, H. H., Elyanow, R., Madsen, A., Trieu, M.-C., et al. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100262 · Cited by 12 · see citing works

The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients

Malahe, S. R. K., den Hartog, Y., Rietdijk, W. J. R., van Baarle, D., de Kuiper, R., Reijerkerk, D., Ras, A. M., Geers, D., Diavatopoulos, D. A., Messchendorp, A. L., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.05.025 · Cited by 12 · see citing works

Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine

Ciabattini, A., Pastore, G., Lucchesi, S., Montesi, G., Costagli, S., Polvere, J., Fiorino, F., Pettini, E., Lippi, A., Ancillotti, L., et al. (2023) · Cells · doi:10.3390/cells12131706 · Cited by 12 · see citing works

Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein

den Hartog, G., Andeweg, S. P., Hoeve, C. E., Smits, G. P., Voordouw, B. C. G., Eggink, D., Knol, M. J., & van Binnendijk, R. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-45718-8 · Cited by 12 · see citing works

The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination

Seong, H., Yoon, J. G., Nham, E., Choi, Y. J., Noh, J. Y., Cheong, H. J., Kim, W. J., Kim, E. H., Kim, C., Han, Y.-H., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05637-2 · Cited by 11 · see citing works

Impairment of Innate Immunity and Depletion of Vaccine‐Induced Memory B and T Cells in the Absence of the Spleen

Bordoni, V., Cinicola, B. L., Mortari, E. P., Castilletti, C., Guarracino, F., Albano, C., Accordini, S., Baban, A., Sabatino, A. D., Rossi, C. M., et al. (2025) · American Journal of Hematology · doi:10.1002/ajh.27634 · Cited by 10 · see citing works

Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters

Mortari, E. P., Pulvirenti, F., Marcellini, V., Terreri, S., Salinas, A. F., Ferrari, S., Napoli, G. D., Guadagnolo, D., Sculco, E., Albano, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1194225 · Cited by 10 · see citing works

SARS-CoV-2–specific mucosal immune response in vaccinated versus infected children

Conti, M. G., Mortari, E. P., Nenna, R., Pierangeli, A., Sorrentino, L., Frasca, F., Petrarca, L., Mancino, E., Mattia, G. D., Matera, L., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1231697 · Cited by 9 · see citing works

Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers

Lochmanová, A., Martínek, J., Tomášková, H., Zelená, H., Dieckmann, K., Grage‐Griebenow, E., Ježo, E., & Janošek, J. (2023) · Diagnostics · doi:10.3390/diagnostics13040637 · Cited by 9 · see citing works

COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants

Stefanelli, P., & Rezza, G. (2022) · Vaccines · doi:10.3390/vaccines10060905 · Cited by 9 · see citing works

High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium

Calcoen, B., Callewaert, N., Vandenbulcke, A., Kerstens, W., Imbrechts, M., Vercruysse, T., Dallmeier, K., Weyenbergh, J. V., Maes, P., Bossuyt, X., et al. (2022) · Viruses · doi:10.3390/v14061257 · Cited by 8 · see citing works

Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients

Ellis, S., Way, R., Nel, M., Burleigh, A., Doykov, I., Kembou-Ringert, J. E., Woodall, M. N. J., Masonou, T., Case, K., Ortiz, A. T., et al. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.11.007 · Cited by 8 · see citing works

Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study

Fujitani, M., Lu, X., Shinnakasu, R., Inoue, T., Kidani, Y., Seki, N. M., Ishida, S., Mitsuki, S., Ishihara, T., Aoki, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550279 · Cited by 8 · see citing works

Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination

Huang, W., Weng, S., Tzeng, H., Yen, F.-C., Chiang, Y.-S., & You, H. (2022) · Vaccines · doi:10.3390/vaccines10091550 · Cited by 8 · see citing works

SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients

Chen, Y., Zhao, T., Chen, L., Jiang, G., Geng, Y., Li, W., Yin, S., Tong, X., Tao, Y., Ni, J., et al. (2024) · mBio · doi:10.1128/mbio.02407-23 · Cited by 8 · see citing works

Polymicrobial biofilms: biological insights and emerging directions in drug discovery

Arasu, A. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2604691 · Cited by 7 · see citing works

The impact of vaccine hesitancy on psychological impairment among healthcare workers in a Total Worker Health© approach

Prinzio, R. R. D., Ceresi, B., Arnesano, G., Dosi, A., Maimone, M., Vacca, M. E., Vinci, M. R., Camisa, V., Santoro, A., Raponi, M., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1447334 · Cited by 6 · see citing works

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

Molinos-Albert, L. M., Rubio, R., Martín-Pérez, C., Pradenas, E., Torres, C., Jiménez, A., Canyelles, M., Vidal, M., Barrios, D., Marfil, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115498 · Cited by 6 · see citing works

Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization

Bertoletti, A., Bert, N. L., & Tan, A. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810679 · Cited by 6 · see citing works

Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan

Sayeed, M. A., Shalim, E., Farooqui, F., Farman, S., Khan, M., Iqbal, A., Ahmed, I., Rajput, A. W., Razzaque, A., & Quraishy, S. (2023) · Vaccines · doi:10.3390/vaccines11071178 · Cited by 6 · see citing works

Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection

Goto, T., Chong, Y., Tani, N., Susai, N., Yoshinaga, T., Sasaki, T., Taniguchi, M., Kusakabe, T., Shimono, N., Akashi, K., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.10.035 · Cited by 6 · see citing works

Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff

Gallichotte, E. N., Nehring, M., Stromberg, S., Young, M. C., Snell, A., Daniels, J., Pabilonia, K. L., VandeWoude, S., Ehrhart, N. P., & Ebel, G. D. (2022) · mSphere · doi:10.1128/msphere.00169-22 · Cited by 6 · see citing works

Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination

Bozhkova, M., Raycheva, R., Petrov, S., Dudova, D., Kalfova, T., Murdjeva, M., Taskov, H. B., & Shivarov, V. S. (2025) · Vaccines · doi:10.3390/vaccines13080799 · Cited by 5 · see citing works

Development of Methods to Produce SARS CoV‐2 Virus‐Like Particles at Scale

Edeling, M. A., Earnest, L., Montoya, J. C., Yap, A. H. Y., Mumford, J., Roberts, J., Wong, C. Y., Hans, D., Grima, J., Bisset, N., et al. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28937 · Cited by 5 · see citing works

The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients

Yang, L., Xiang, F., Wang, D., Guo, Q., Deng, B., Jiang, D., & Ren, H. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04566-0 · Cited by 5 · see citing works

Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients

Bader, G., Itan, M., Edry‐Botzer, L., Cohen, H., Haskin, O., Mozer‐Glassberg, Y., Harel, L., Munitz, A., Marcus, N., & Gerlic, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1131965 · Cited by 5 · see citing works

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine

He, X., Cao, Y., Lu, Y., Qi, F., Wang, H., Liao, X., Xu, G., Yang, B., Ma, J., Li, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1181121 · Cited by 5 · see citing works

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer

Li, T., Song, R., Wang, J., Zhang, J., Cai, H., He, H., Hu, W., Yu, D., Wang, C., Pan, Q., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.07.050 · Cited by 5 · see citing works

Airway and Systemic Immune Responses Following the Third COVID-19 Vaccination in COPD Patients

Southworth, T. W., Jackson, N. A., & Singh, D. (2023) · International Journal of COPD · doi:10.2147/copd.s433269 · Cited by 5 · see citing works

Ad5-nCoV Vaccination Could Induce HLA-E Restricted CD8+ T Cell Responses Specific for Epitopes on Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein

Wang, Y., Yang, L., Tang, K., Zhang, Y., Zhang, C., Zhang, Y., Jin, B., Zhang, Y., Zhuang, R., & Ma, Y. (2023) · Viruses · doi:10.3390/v16010052 · Cited by 4 · see citing works

Immunological memory in infected & exposure näive individuals one year post SARS-CoV-2 vaccination

Das, P., Varun, C. N., Ashwini, M. A., Kesavan, M., Ravi, V., & Desai, A. S. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_923_2024 · Cited by 4 · see citing works

COVID-19 infection and vaccination in immunodeficiency

Mortari, E. P., & Pulvirenti, F. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac080 · Cited by 4 · see citing works

Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases

Yang, L., Xu, L., Guo, Q., Deng, B., Hong, Y., Wang, L., Wang, Y., Jiang, D., & Ren, H. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.78766 · Cited by 3 · see citing works

Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2

Geropeppa, M., Papadatou, I., Sarantis, P., Tzanoudaki, M., Ntanasis‐Stathopoulos, I., Bagratuni, T., Terpos, E., & Spoulou, V. I. (2023) · Vaccines · doi:10.3390/vaccines11071148 · Cited by 3 · see citing works

Antibody immunotherapies for personalized opioid addiction treatment

Rosenn, E. H., Korlansky, M., Benyaminpour, S., Munarova, V., Fox, E., Shah, D., Durham, A., Less, N., & Pasinetti, G. M. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103522 · Cited by 3 · see citing works

Single-Cell RNA Sequencing of Baseline Immune Profiles After Third Vaccination Associated with Subsequent SARS-CoV-2 Infection in Naïve Individuals

Kang, H., Park, J., Bae, H., Chung, Y., & Oh, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083494 · Cited by 3 · see citing works

Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure

Stefanski, A., Rincón-Arévalo, H., Schrezenmeier, E. V., Karberg, K., Szelinski, F., Ritter, J., Chen, Y., Meisel, C., Jahrsdörfer, B., Ludwig, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.943476 · Cited by 3 · see citing works

Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters

Yang, Z., Song, Y., Pei, J., Li, S.-Z., Liu, R.-L., Xiong, Y., Wu, J., Liu, Y.-L., Fan, H.-F., Wu, J., et al. (2024) · Viruses · doi:10.3390/v16040559 · Cited by 2 · see citing works

Immune response and associated factors to Hepatitis B vaccination among children under five attending care at mulago hospital

Kimera, A., Rujumba, J., Ndikuno, C. K., Ndeezi, G., Mukiza, N., Basenero, A., Piloya, T., Bakeera‐Kitaka, S., Nabulya, R., Nalumansi, A. M., et al. (2025) · BMC Pediatrics · doi:10.1186/s12887-024-05366-x · Cited by 2 · see citing works

Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination

Torre, D. L., Orlandi, C., Conti, I., Barocci, S., Carlotti, E., Magnani, M., Casabianca, A., & Stefanetti, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1579163 · Cited by 2 · see citing works

Investigating the Impact of Peptide-Based Vaccines on Various Types of Cancer: A Systematic Review

Esmaeili, A. (2025) · Cancer Investigation · doi:10.1080/07357907.2025.2568964 · Cited by 2 · see citing works

The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination—lessons learned from the SARS-CoV-2 pandemic

Bjarnarson, S. P., & Brynjolfsson, S. F. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac113 · Cited by 2 · see citing works

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience

Pulvirenti, F., Garzi, G., Milito, C., Sculco, E., Sciannamea, M., Napoli, A., Cinti, L., Roberto, P., Punziano, A., Carrabba, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1249462 · Cited by 2 · see citing works

Relationship between B-Cell Populations, Development and Function of B-Cell Subsets

Mortari, E. P., & Carsetti, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95895-0.00022-2 · Cited by 1 · see citing works

Effectiveness of bivalent COVID-19 vaccines against SARS-CoV-2 reinfection in patients with cancer: Evidence from a nationwide target trial emulation

Kim, H.-K., Jo, S., Min, K., & Cho, S. (2026) · Journal of Infection · doi:10.1016/j.jinf.2026.106753 · Cited by 1 · see citing works

Longitudinal humoral and memory B-cell responses to repeated SARS-CoV-2 vaccination in long-term care facilities residents

Palmieri, A., Damiano, C., Leone, P., Sugoni, C., Albano, C., Mortari, E. P., Schiavoni, I., Trevisan, C., Malara, A., Zucchelli, A., et al. (2026) · Immunity & Ageing · doi:10.1186/s12979-026-00581-9 · Cited by 1 · see citing works

COVID-19 vaccination: challenges in the pediatric population

Azoicai, A. N., Miron, I. C., Lupu, A., Alexoae, M. M., Stârcea, I. M., Alecsa, M., Lupu, V. V., Danielescu, C., Nedelcu, A. H., Șalaru, D. L., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1390951 · Cited by 1 · see citing works

Dominant and cross-reactive S1-specific memory B cell response induced by primary SARS-CoV-2 infection

Xing, X., Zhang, Z., Wen, Y., Guo, W., Zhang, X., Min, Y., Zhong, K., Zhang, L., Wei, P., Zhang, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-06847-4 · Cited by 1 · see citing works

The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost

Lima, N. S., McCormick, L., Li, S., Wake, C., Subramanian, R., Spangler, A., Pinto, Y., Catalano, W. L., Henry, A. R., Laboune, F., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aeb9837 · Cited by 1 · see citing works

Olfactory immunity: defending the neural-mucosal barrier

Tracey, S., & Moseman, E. A. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf326 · Cited by 1 · see citing works

Short‐Term Promotion of Beneficial Skin Commensal Staphylococcus Species Growth by PS‐B1, a Postbiotic Composed of Lactic Acid Bacteria‐Fermented Soy Milk

Funatsu, O., Ishii, H., Shimatsu, R., Shimokawa, Y., Asahina, A., & Dekio, I. (2026) · Microbiology and Immunology · doi:10.1111/1348-0421.70057 · Cited by 1 · see citing works

Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2

Athavale, A., Gaur, A., Ahmed, N., Subramaniam, A., Dandotiya, J., Raj, S., Upadhyay, S. K., Samal, S., Pandey, A. K., Rai, R. C., et al. (2024) · Vaccines · doi:10.3390/vaccines12121396 · Cited by 1 · see citing works

Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine

Wang, X., Yang, X., Zhang, X., Yan, H., Jin, J., Ma, Z., Duan, J., Zhang, G., Huang, T., Li, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1554409 · Cited by 1 · see citing works

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves

Chandrasingh, S., George, C. E., Inbaraj, L. R., & Maddipati, T. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1809_22 · Cited by 1 · see citing works

Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animalsPreprint

Schultz, M. D., Botta, D., Silva-Sánchez, A., Cheatwood, I. R., Kalange, D., Terapane, S. M., Lucander, A. C. K., Zhou, F., Akther, J., Yang, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.13.682194 · Cited by 1 · see citing works

Waning of Serum Antibodies, But Increase of Protective B-Cell Memory Nine Months After BNT162b2 VaccinationPreprint

Terreri, S., Mortari, E. P., Vinci, M. R., Russo, C., Alteri, C., Albano, C., Linardos, G., Colagrossi, L., Deriu, G., Atti, M. L. C. D., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3956432

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

Molinos-Albert, L. M., Rubio, R., Martín-Pérez, C., Pradenas, E., Torres, C., Jiménez, A., Canyelles, M., Vidal, M., Barrios, D., Marfil, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115498 · Cited by 6 · see citing works

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies

Mazzoni, A., Vanni, A., Spinicci, M., Lamacchia, G., Kiros, S. T., Rocca, A., Capone, M., Lauria, N. D., Salvati, L., Carnasciali, A., et al. (2022) · Greater South Information System · doi:10.60692/ra38y-2e405

Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination

Fryer, H. A., Hartley, G. E., Edwards, E. S. J., O’Hehir, R. E., & van Zelm, M. C. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220415 · Cited by 16 · see citing works

Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response

Pušnik, J., König, J., Mai, K., Richter, E., Zorn, J., Proksch, H., Schulte, B., Alter, G., & Streeck, H. (2022) · Journal of Virology · doi:10.1128/jvi.00760-22 · Cited by 27 · see citing works